These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 24262661)

  • 1. MiR-200, a new star miRNA in human cancer.
    Feng X; Wang Z; Fillmore R; Xi Y
    Cancer Lett; 2014 Mar; 344(2):166-73. PubMed ID: 24262661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-29b: an emerging player in human cancer.
    Liu H; Wang B; Lin J; Zhao L
    Asian Pac J Cancer Prev; 2014; 15(21):9059-64. PubMed ID: 25422179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.
    Koutsaki M; Spandidos DA; Zaravinos A
    Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
    Gunaratne PH
    Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Regulation of Human Breast Cancer Stem Cells.
    Shimono Y; Mukohyama J; Nakamura S; Minami H
    J Clin Med; 2015 Dec; 5(1):. PubMed ID: 26712794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA and mRNA expression profiling identifies members of the miR-200 family as potential regulators of epithelial-mesenchymal transition in pterygium.
    Engelsvold DH; Utheim TP; Olstad OK; Gonzalez P; Eidet JR; Lyberg T; Trøseid AM; Dartt DA; Raeder S
    Exp Eye Res; 2013 Oct; 115():189-98. PubMed ID: 23872359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
    Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
    PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dual regulatory role of miR-204 in cancer.
    Li T; Pan H; Li R
    Tumour Biol; 2016 Sep; 37(9):11667-11677. PubMed ID: 27438705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the miR-200 family in epithelial-mesenchymal transition.
    Mongroo PS; Rustgi AK
    Cancer Biol Ther; 2010 Aug; 10(3):219-22. PubMed ID: 20592490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive role of dysregulated miRNAs in chordoma cancer stem-like cell maintenance.
    Tuysuz EC; Gulluoglu S; Yaltirik CK; Ozbey U; Kuskucu A; Çoban EA; Sahin F; Türe U; Bayrak OF
    Exp Cell Res; 2019 Jul; 380(1):9-19. PubMed ID: 30951707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy.
    Liang Y; Li S; Tang L
    Biomedicines; 2021 May; 9(6):. PubMed ID: 34071109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting the miR-200 Family: A Clan of Five Siblings with Essential Roles in Development and Disease.
    Sundararajan V; Burk UC; Bajdak-Rusinek K
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
    Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
    EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence diverse miRNAs converge to induce mesenchymal-to-epithelial transition in ovarian cancer cells through direct and indirect regulatory controls.
    Zhang M; Jabbari N; Satpathy M; Matyunina LV; Wang Y; McDonald LD; McDonald JF
    Cancer Lett; 2019 Sep; 459():168-175. PubMed ID: 31163194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells.
    Du R; Sun W; Xia L; Zhao A; Yu Y; Zhao L; Wang H; Huang C; Sun S
    PLoS One; 2012; 7(2):e30771. PubMed ID: 22363487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNAs as oncogenes and tumor suppressors.
    Zhang B; Pan X; Cobb GP; Anderson TA
    Dev Biol; 2007 Feb; 302(1):1-12. PubMed ID: 16989803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of miR-200 family members in lung cancer: more than tumor suppressors.
    Liu C; Hu W; Li LL; Wang YX; Zhou Q; Zhang F; Song-Yang YY; Zhu W; Sun CC; Li DJ
    Future Oncol; 2018 Nov; 14(27):2875-2886. PubMed ID: 30208739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-613: A novel tumor suppressor in human cancers.
    Mei J; Xu R; Hao L; Zhang Y
    Biomed Pharmacother; 2020 Mar; 123():109799. PubMed ID: 31877552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.